Exploring the Antisnake Venom Potential of <i>Zingiber officinale</i> and its Bioactive Compounds Against <i>Naja nigricollis</i> Venom Through Computational Approaches and Experimental Validation

Snakebite envenomation remains a significant medical challenge, particularly in tropical and subtropical regions. The present study investigates the inhibitory potential of Zingiber officinale (ginger) and its bioactive compounds against Naja nigricollis venom using in silico approaches and animal models. No protection was observed in the in vivo studies but the extract of the plant was able to prolong the time of death with mean survival time ranging from 2.01-2.83 hours. In terms of the in vitro studies, the extract was able to significantly (p<0.05) detoxify the N. nigricollis venom by 80 % at the graded doses; standard antisnake venom (ASV) offered 100 % protection to mice. Molecular docking analysis revealed strong binding affinities between the bioactive compounds and the PLA₂ enzyme, indicating potential inhibitory effects. The stability and dynamics of the protein-ligand complexes were further validated through molecular dynamics (MD) simulations, which confirmed the persistence of these interactions over time. In conclusion, the findings suggest that the bioactive compounds from Z. officinale could serve as promising inhibitors of PLA₂, providing a foundation for the development of novel snakebite envenomation therapies.